Literature DB >> 25944640

On the safety of intravenous iron, evidence trumps conjecture.

Michael Auerbach1, John Adamson2, Andreas Bircher3, Christian Breymann4, Steven Fishbane5, Anat Gafter-Gvili6, Christoph Gasche7, Jeffrey Gilreath8, Giuliano Grazzini9, David Henry10, Giancarlo Liumbruno9, Francesco Locatelli11, Iain Macdougall12, Manuel Munoz13, David Rampton14, George Rodgers15, Aryeh Shander16.   

Abstract

Entities:  

Keywords:  current; efficacy; evidence; intravenous iron formulations; safety; studies

Mesh：

Substances：

Year:  2015        PMID： 25944640      PMCID： PMC4420237          DOI： 10.3324/haematol.2014.121004

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  Use of parenteral iron products and serious anaphylactic-type reactions.

Authors:  Diane K Wysowski; Lynette Swartz; B Vicky Borders-Hemphill; Margie R Goulding; Catherine Dormitzer
Journal:  Am J Hematol       Date:  2010-09       Impact factor: 10.047

2.  High-molecular weight iron dextran: a wolf in sheep's clothing?

Authors:  George M Rodgers; Michael Auerbach; David Cella; Glenn M Chertow; Daniel W Coyne; John A Glaspy; David H Henry
Journal:  J Am Soc Nephrol       Date:  2008-03-27       Impact factor: 10.121

3.  Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia.

Authors:  Michael Auerbach; Jennifer A Pappadakis; Huzefa Bahrain; Sarah A Auerbach; Harold Ballard; Naomi V Dahl
Journal:  Am J Hematol       Date:  2011-08-29       Impact factor: 10.047

Review 4.  The safety of intravenous iron preparations: systematic review and meta-analysis.

Authors:  Tomer Avni; Amir Bieber; Alon Grossman; Hefziba Green; Leonard Leibovici; Anat Gafter-Gvili
Journal:  Mayo Clin Proc       Date:  2014-10-30       Impact factor: 7.616

5.  Comparative rates of adverse events with different formulations of intravenous iron.

Authors:  Maureen M Okam; Elyse Mandell; Nathanael Hevelone; Rachel Wentz; Ainsley Ross; Gregory A Abel
Journal:  Am J Hematol       Date:  2012-09-11       Impact factor: 10.047

6.  Update on adverse drug events associated with parenteral iron.

Authors:  Glenn M Chertow; Phillip D Mason; Odd Vaage-Nilsen; Jarl Ahlmén
Journal:  Nephrol Dial Transplant       Date:  2005-11-11       Impact factor: 5.992

7.  The safety of intravenous iron dextran in hemodialysis patients.

Authors:  S Fishbane; V D Ungureanu; J K Maesaka; C J Kaupke; V Lim; J Wish
Journal:  Am J Kidney Dis       Date:  1996-10       Impact factor: 8.860

Review 8.  Hypersensitivity from intravenous iron products.

Authors:  Andreas J Bircher; Michael Auerbach
Journal:  Immunol Allergy Clin North Am       Date:  2014-08       Impact factor: 3.479

9.  A systematic analysis of global anemia burden from 1990 to 2010.

Authors:  Nicholas J Kassebaum; Rashmi Jasrasaria; Mohsen Naghavi; Sarah K Wulf; Nicole Johns; Rafael Lozano; Mathilda Regan; David Weatherall; David P Chou; Thomas P Eisele; Seth R Flaxman; Rachel L Pullan; Simon J Brooker; Christopher J L Murray
Journal:  Blood       Date:  2013-12-02       Impact factor: 22.113

10.  Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia.

Authors:  Iftikhar Hussain; Jessica Bhoyroo; Angelia Butcher; Todd A Koch; Andy He; David B Bregman
Journal:  Anemia       Date:  2013-08-29
View more
  16 in total

1.  A fast-track anaemia clinic in the Emergency Department: cost-analysis of intravenous iron administration for treating iron-deficiency anaemia.

Authors:  Manuel Quintana-Díaz; Raúl Muñoz-Romo; Susana Gómez-Ramírez; José Pavía; Alberto M Borobia; José A García-Erce; Manuel Muñoz
Journal:  Blood Transfus       Date:  2017-01-24       Impact factor: 3.443

2.  The Italian Regulatory Guidelines for the implementation of Patient Blood Management.

Authors:  Stefania Vaglio; Sara Gentili; Giuseppe Marano; Simonetta Pupella; Daniela Rafanelli; Gianni Biancofiore; Paola Antonioli; Claudio Velati; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2017-05-03       Impact factor: 3.443

3.  Early intravenous iron administration in the Emergency Department reduces red blood cell unit transfusion, hospitalisation, re-transfusion, length of stay and costs.

Authors:  Ivo Beverina; Giancarlo Razionale; Monica Ranzini; Alessandro Aloni; Sergio Finazzi; Bruno Brando
Journal:  Blood Transfus       Date:  2019-12-17       Impact factor: 3.443

Review 4.  Prevention and management of acute reactions to intravenous iron in surgical patients.

Authors:  Susana Gómez-Ramírez; Aryeh Shander; Donat R Spahn; Michael Auerbach; Giancarlo M Liumbruno; Stefania Vaglio; Manuel Muñoz
Journal:  Blood Transfus       Date:  2018-10-16       Impact factor: 3.443

5.  Intravenous ferric carboxymaltose is effective and safe in patients with inflammatory rheumatic diseases.

Authors:  Ugo Salvadori; Fabio Vittadello; Ahmad Al-Khaffaf; Armin Maier; Paola C Cappelletto; Massimo Daves; Bernd Raffeiner
Journal:  Blood Transfus       Date:  2019-12-13       Impact factor: 3.443

6.  New developments and controversies in iron metabolism and iron chelation therapy.

Authors:  Christina N Kontoghiorghe; George J Kontoghiorghes
Journal:  World J Methodol       Date:  2016-03-26

7.  Impact of European medicines agency recommendations for hypersensitivity reactions on intravenous iron prescription in haemodialysis centres of the Lombardy region.

Authors:  Rodolfo F Rivera; Davide Guido; Lucia Del Vecchio; Enzo Corghi; Marco D'Amico; Corrado Camerini; Donatella Spotti; Andrea Galassi; Claudio Pozzi; Giovanni Cancarini; Giuseppe Pontoriero; Francesco Locatelli
Journal:  J Nephrol       Date:  2015-12-29       Impact factor: 3.902

8.  Adverse Reactions After Intravenous Iron Infusion Among Inflammatory Bowel Disease Patients in the United States, 2010-2014.

Authors:  Eboselume Akhuemonkhan; Alyssa Parian; Kathryn A Carson; Susan Hutfless
Journal:  Inflamm Bowel Dis       Date:  2018-07-12       Impact factor: 5.325

Review 9.  Current misconceptions in diagnosis and management of iron deficiency.

Authors:  Manuel Muñoz; Susana Gómez-Ramírez; Martin Besser; José Pavía; Fernando Gomollón; Giancarlo M Liumbruno; Sunil Bhandari; Mercé Cladellas; Aryeh Shander; Michael Auerbach
Journal:  Blood Transfus       Date:  2017-09       Impact factor: 3.443

10.  A fast-track anaemia clinic in the Emergency Department: feasibility and efficacy of intravenous iron administration for treating sub-acute iron deficiency anaemia.

Authors:  Manuel Quintana-Díaz; Sara Fabra-Cadenas; Susana Gómez-Ramírez; Ana Martínez-Virto; José A García-Erce; Manuel Muñoz
Journal:  Blood Transfus       Date:  2015-11-19       Impact factor: 3.443
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.